Considering TMPRSS2 is mainly expressed in prostate cancer, we conclude that CTSL mutations primarily correlated with FURIN expression, which might further regulate SARS-CoV-2 entry in cancers. Here, TMPRSS2 is linked to prostate carcinoma.